Clinical Trials Browser

Phase 1/2 × guadecitabine × Gastrointestinal × Clear all

NCT03576963 2021-04-05

Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Neoplasms